OPTHF
Price
$0.17
Change
+$0.02 (+13.33%)
Updated
Sep 5 closing price
Capitalization
16.09M
VRNOF
Price
$1.34
Change
+$0.07 (+5.51%)
Updated
Sep 5 closing price
Capitalization
484.42M
71 days until earnings call
Interact to see
Advertisement

OPTHF vs VRNOF

Header iconOPTHF vs VRNOF Comparison
Open Charts OPTHF vs VRNOFBanner chart's image
OPTIMI HEALTH
Price$0.17
Change+$0.02 (+13.33%)
Volume$500
Capitalization16.09M
Verano Holdings
Price$1.34
Change+$0.07 (+5.51%)
Volume$324.73K
Capitalization484.42M
OPTHF vs VRNOF Comparison Chart in %
Loading...
OPTHF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VRNOF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
OPTHF vs. VRNOF commentary
Sep 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is OPTHF is a Hold and VRNOF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 08, 2025
Stock price -- (OPTHF: $0.17 vs. VRNOF: $1.34)
Brand notoriety: OPTHF and VRNOF are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: OPTHF: 3% vs. VRNOF: 30%
Market capitalization -- OPTHF: $16.09M vs. VRNOF: $484.42M
OPTHF [@Pharmaceuticals: Generic] is valued at $16.09M. VRNOF’s [@Pharmaceuticals: Generic] market capitalization is $484.42M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $67.95B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.93B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

OPTHF’s FA Score shows that 0 FA rating(s) are green whileVRNOF’s FA Score has 1 green FA rating(s).

  • OPTHF’s FA Score: 0 green, 5 red.
  • VRNOF’s FA Score: 1 green, 4 red.
According to our system of comparison, both OPTHF and VRNOF are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

OPTHF’s TA Score shows that 4 TA indicator(s) are bullish while VRNOF’s TA Score has 4 bullish TA indicator(s).

  • OPTHF’s TA Score: 4 bullish, 5 bearish.
  • VRNOF’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, both OPTHF and VRNOF are a bad buy in the short-term.

Price Growth

OPTHF (@Pharmaceuticals: Generic) experienced а +5.39% price change this week, while VRNOF (@Pharmaceuticals: Generic) price change was -21.18% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -0.10%. For the same industry, the average monthly price growth was +9.01%, and the average quarterly price growth was +87.11%.

Reported Earning Dates

VRNOF is expected to report earnings on Nov 18, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (-0.10% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VRNOF($484M) has a higher market cap than OPTHF($16.1M). OPTHF YTD gains are higher at: 8.960 vs. VRNOF (7.631). OPTHF has higher annual earnings (EBITDA): -3.42M vs. VRNOF (-98.31M). VRNOF has more cash in the bank: 68.6M vs. OPTHF (55.7K). OPTHF has less debt than VRNOF: OPTHF (2.83M) vs VRNOF (509M). VRNOF has higher revenues than OPTHF: VRNOF (847M) vs OPTHF (496K).
OPTHFVRNOFOPTHF / VRNOF
Capitalization16.1M484M3%
EBITDA-3.42M-98.31M3%
Gain YTD8.9607.631117%
P/E RatioN/AN/A-
Revenue496K847M0%
Total Cash55.7K68.6M0%
Total Debt2.83M509M1%
TECHNICAL ANALYSIS
Technical Analysis
OPTHFVRNOF
RSI
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
82%
Momentum
ODDS (%)
Bullish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
MACD
ODDS (%)
N/A
Bearish Trend 4 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
83%
Bearish Trend 4 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
83%
Bullish Trend 4 days ago
73%
Advances
ODDS (%)
Bullish Trend 7 days ago
88%
Bullish Trend 4 days ago
76%
Declines
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 6 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
73%
View a ticker or compare two or three
Interact to see
Advertisement
OPTHF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VRNOF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
IIDDY6.40N/A
N/A
IGO Ltd
KOGL57.00N/A
N/A
Kopp Glass, Inc.
MSLOF33.51N/A
N/A
Mitsui O.S.K. Lines Ltd.
NWPHF9.36N/A
N/A
Newron Pharmaceuticals SPA
RRDMF0.09N/A
-3.26%
Royal Road Minerals Limited

OPTHF and

Correlation & Price change

A.I.dvisor tells us that OPTHF and GLASF have been poorly correlated (+5% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that OPTHF and GLASF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OPTHF
1D Price
Change %
OPTHF100%
+13.53%
GLASF - OPTHF
5%
Poorly correlated
+3.99%
SEHCF - OPTHF
4%
Poorly correlated
N/A
BGPPF - OPTHF
3%
Poorly correlated
N/A
GEDSF - OPTHF
3%
Poorly correlated
N/A
VRNOF - OPTHF
2%
Poorly correlated
+5.51%
More

VRNOF and

Correlation & Price change

A.I.dvisor indicates that over the last year, VRNOF has been closely correlated with GTBIF. These tickers have moved in lockstep 79% of the time. This A.I.-generated data suggests there is a high statistical probability that if VRNOF jumps, then GTBIF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VRNOF
1D Price
Change %
VRNOF100%
+5.51%
GTBIF - VRNOF
79%
Closely correlated
+4.55%
CURLF - VRNOF
77%
Closely correlated
+1.79%
TCNNF - VRNOF
76%
Closely correlated
+4.55%
TSNDF - VRNOF
73%
Closely correlated
+13.08%
CRLBF - VRNOF
72%
Closely correlated
+5.26%
More